about
Traumatic brain injury-induced cognitive and histological deficits are attenuated by delayed and chronic treatment with the 5-HT1A-receptor agonist buspironeA delayed and chronic treatment regimen with the 5-HT1A receptor agonist 8-OH-DPAT after cortical impact injury facilitates motor recovery and acquisition of spatial learningCombination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better?Environmental enrichment promotes robust functional and histological benefits in female rats after controlled cortical impact injuryA combined therapeutic regimen of buspirone and environmental enrichment is more efficacious than either alone in enhancing spatial learning in brain-injured pediatric ratsOld dog, new tricks: the attentional set-shifting test as a novel cognitive behavioral task after controlled cortical impact injury.Empirical comparison of typical and atypical environmental enrichment paradigms on functional and histological outcome after experimental traumatic brain injury.Environmental enrichment-mediated functional improvement after experimental traumatic brain injury is contingent on task-specific neurobehavioral experience.Chronic administration of antipsychotics impede behavioral recovery after experimental traumatic brain injury.Acute treatment with the 5-HT(1A) receptor agonist 8-OH-DPAT and chronic environmental enrichment confer neurobehavioral benefit after experimental brain trauma.The neurobehavioral benefit conferred by a single systemic administration of 8-OH-DPAT after brain trauma is confined to a narrow therapeutic window.Elucidating the role of 5-HT(1A) and 5-HT(7) receptors on 8-OH-DPAT-induced behavioral recovery after experimental traumatic brain injury.Evaluation of a combined treatment paradigm consisting of environmental enrichment and the 5-HT1A receptor agonist buspirone after experimental traumatic brain injury.A relatively brief exposure to environmental enrichment after experimental traumatic brain injury confers long-term cognitive benefitsAdministration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficitsDose-dependent neurorestorative effects of amantadine after cortical impact injury
P50
Q24633449-B30C59F1-F65E-4178-8623-AC2B99A6D3E3Q24651403-7438393F-0306-41B7-9323-AF7F9DDD9376Q28397361-A061F8FC-9993-42F1-A289-F0EE5FE809C0Q28397697-44983EFD-5691-4480-B3DE-CBF2C0DEEFC5Q28397908-B1A1529B-109F-41DD-A2F3-249E3390CB07Q33576385-DF308641-EC1D-486D-BFF4-9B6C62C4D689Q34145744-5A64F7DC-DE1B-4C49-8F56-AB63F55458BCQ34660115-8559EB59-BB9A-4594-AEBC-4E83EB2F34B0Q34660141-8CD3C433-ED32-4068-9940-655526AEAA04Q35746505-B562BBE6-E8B0-422A-95F0-424986E28C65Q35809500-703CED77-87BD-496B-A117-13E65E3B814EQ35894821-4278609C-3243-4871-A48F-41EA442574A1Q36079887-7090AC94-DA4D-409E-ADEB-652A0494CCC2Q36434945-885EB0E1-0A8E-4C37-864A-67438A7B5D3CQ37018684-62660034-337D-4DDF-9A21-EFDF0536C513Q93345649-D6766A61-8D09-4FF2-9D63-152EB73CE166
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jeffrey Cheng
@ast
Jeffrey Cheng
@en
Jeffrey Cheng
@es
Jeffrey Cheng
@nl
Jeffrey Cheng
@sl
type
label
Jeffrey Cheng
@ast
Jeffrey Cheng
@en
Jeffrey Cheng
@es
Jeffrey Cheng
@nl
Jeffrey Cheng
@sl
prefLabel
Jeffrey Cheng
@ast
Jeffrey Cheng
@en
Jeffrey Cheng
@es
Jeffrey Cheng
@nl
Jeffrey Cheng
@sl
P106
P1153
16041694300
56427247100
P21
P31
P496
0000-0001-8285-3207